We are live on ! Find out more
ADIM

Alpha DNA Investment Management Portfolio holdings

AUM $8.98M
1-Year Est. Return 26.05%
This Fund
S&P 500
This Quarter Est. Return
+14.27%
1 Year Est. Return
+26.05%
3 Year Est. Return
+134.39%
5 Year Est. Return
10 Year Est. Return
AUM
$256M
AUM Growth
+$12.2M
Cap. Flow
-$14.2M
Cap. Flow %
-5.52%
Top 10 Hldgs %
47.16%
Holding
248
New
79
Increased
35
Reduced
67
Closed
65

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$2.6M
2
EOG icon
EOG Resources
EOG
+$2.56M
3
CVX icon
Chevron
CVX
+$2.51M
4
KVUE icon
Kenvue
KVUE
+$1.8M
5
NEE icon
NextEra Energy
NEE
+$1.79M

Top Sells

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$3M
2
PPG icon
PPG Industries
PPG
+$2.06M
3
CL icon
Colgate-Palmolive
CL
+$1.74M
4
MCD icon
McDonald's
MCD
+$1.67M
5
RTX icon
RTX Corp
RTX
+$1.53M

Sector Composition

Rank Sector Weight
1 Technology 17.66%
2 Financials 12.3%
3 Healthcare 9.54%
4 Energy 5.49%
5 Consumer Staples 5.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SITE icon
176
SiteOne Landscape Supply
SITE
$4.32B
$241K 0.09%
+1,485
New +$216K
OBDC icon
177
Blue Owl Capital
OBDC
$5.76B
$238K 0.09%
+16,092
New +$229K
PBF icon
178
PBF Energy
PBF
$8.22B
$217K 0.08%
+4,927
New +$224K
TRV icon
179
Travelers Companies
TRV
$78.3B
$207K 0.08%
+1,085
New +$188K
SPY icon
180
State Street SPDR S&P 500 ETF Trust
SPY
$807B
$175K 0.07%
368
+39
+12% +$17.4K
IWM icon
181
CALL
iShares Russell 2000 ETF
IWM
$81.8B
$100K 0.04%
+500
New +$89.6K
SPY icon
182
CALL
State Street SPDR S&P 500 ETF Trust
SPY
$807B
$47.5K 0.02%
100
IWM icon
183
iShares Russell 2000 ETF
IWM
$81.8B
$201 ﹤0.01%
1
ADUS icon
184
Addus HomeCare
ADUS
$2.18B
-6,026
Closed -$513K
AMPL icon
185
Amplitude
AMPL
$1.59B
-46,991
Closed -$544K
AMZN icon
186
Amazon
AMZN
$2.94T
-6,755
Closed -$859K
ANIP icon
187
ANI Pharmaceuticals
ANIP
$1.71B
-9,627
Closed -$559K
APTV icon
188
Aptiv
APTV
$10.3B
-8,124
Closed -$801K
ARVN icon
189
Arvinas
ARVN
$588M
-26,759
Closed -$526K
ATEC icon
190
Alphatec Holdings
ATEC
$1.45B
-36,660
Closed -$475K
AZEK
191
DELISTED
The AZEK Co
AZEK
-17,181
Closed -$511K
BCYC
192
Bicycle Therapeutics
BCYC
$288M
-27,957
Closed -$562K
BZH icon
193
Beazer Homes USA
BZH
$874M
-22,251
Closed -$554K
CARR icon
194
Carrier Global
CARR
$52.4B
-14,661
Closed -$809K
CAT icon
195
Caterpillar
CAT
$388B
-2,874
Closed -$785K
CL icon
196
Colgate-Palmolive
CL
$73.6B
-24,532
Closed -$1.74M
CNX icon
197
CNX Resources
CNX
$5.35B
-26,003
Closed -$587K
COTY icon
198
Coty
COTY
$2.48B
-49,224
Closed -$540K
CSTL icon
199
Castle Biosciences
CSTL
$985M
-29,399
Closed -$497K
CXM icon
200
Sprinklr
CXM
$1.61B
-39,976
Closed -$553K

Similar funds

Alpha DNA Investment Management's Q4 2023 Portfolio in Review

As of Q4 2023, Alpha DNA Investment Management held 248 positions worth $256M, up 5% from $244M the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Alpha DNA Investment Management withdrew a net $14.2M in Q4 2023, closing 65 positions and reducing 67 holdings. Its most notable exit was Eli Lilly, an estimated $3M position sold in full.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 13% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Alpha DNA Investment Management opened a new position in Kenvue worth $1.93M.

  • Alpha DNA Investment Management's largest Q4 2023 buy was Kenvue: 89,868 shares worth $1.93M.
  • Alpha DNA Investment Management added most to Microsoft in Q4 2023, an estimated $2.6M increase.
  • Alpha DNA Investment Management's biggest Q4 2023 reduction was PPG Industries, cutting an estimated $2.06M.
  • Alpha DNA Investment Management fully exited Eli Lilly in Q4 2023, selling an estimated $3M.
  • Alpha DNA Investment Management's ten largest holdings make up 47% of its $256M portfolio in Q4 2023.
  • Alpha DNA Investment Management opened 79 new positions and closed 65 in Q4 2023.
  • Alpha DNA Investment Management's portfolio value rose 5% quarter-over-quarter to $256M.

Based on Alpha DNA Investment Management's 13F filing for Q4 2023, filed 12 Feb 2024.